Immune-checkpoint inhibitors and neurological adverse events

Sudhakar Tummala

doi:10.1016/S1474-4422(23)00413-1

Immune-checkpoint inhibitors and neurological adverse events

Sudhakar Tummala

Neuro-Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1093-1094
Number of pages	2
Journal	The Lancet Neurology
Volume	22
Issue number	12
DOIs	https://doi.org/10.1016/S1474-4422(23)00413-1
State	Published - Dec 2023

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/S1474-4422(23)00413-1

Cite this

@article{5b97cd6c53ec4d93b27809265dfcedac,

title = "Immune-checkpoint inhibitors and neurological adverse events",

author = "Sudhakar Tummala",

year = "2023",

month = dec,

doi = "10.1016/S1474-4422(23)00413-1",

language = "English (US)",

volume = "22",

pages = "1093--1094",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "12",

}

TY - JOUR

T1 - Immune-checkpoint inhibitors and neurological adverse events

AU - Tummala, Sudhakar

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85176752915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85176752915&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(23)00413-1

DO - 10.1016/S1474-4422(23)00413-1

M3 - Comment/debate

C2 - 37977701

AN - SCOPUS:85176752915

SN - 1474-4422

VL - 22

SP - 1093

EP - 1094

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 12

ER -

Immune-checkpoint inhibitors and neurological adverse events

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this